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Community-acquired pneumonia (CAP) is the third leading cause of hospitalization 
among children in the U.S. This research project is comprised of three studies of children with 
CAP. The data were collected for the CDC’s Etiology of Pneumonia in the Community (EPIC) 
study. Study one aimed to examine the association of clinical factors with potentially 
unnecessary hospitalizations, as defined by a length of stay (LOS) in the hospital ≤ 24 hours. 
Study two aimed to validate the Canadian Acute Respiratory Illness and Flu Scale (CARIFS) 
questionnaire among an inpatient pediatric population with CAP. This study also examined the 
utility of the CARIFS questionnaire in predicting LOS in the hospital. Study three examined 
factors that could influence parental consent for their child to participate in research. Participants 
were children, 0-18 years old, classified into five age-categories, who were hospitalized with 
CAP at one of three sites: Le Bonheur Children's Hospital, Monroe Carell Jr. Children's Hospital 
at Vanderbilt and Primary Children's Hospital. A short length of stay, ≤ 24 hours, was associated 
across all ages with higher oxygen saturation level at admission. Study two, the CARIFS survey, 
had high internal reliability among this population (Cronbach’s alpha = 0.89). The 18 CARIFS 
questions loaded onto four domains (physical function, parental impact, subjective symptoms 
and objective symptoms). Except for infants, the more severe the symptoms of physical function, 
the longer the LOS. In study three, households with less education were more likely to give 
consent for their child to participate than those with a college degree (OR = 4.78, 95% CI = 1.75, 
13.05). Desire to learn more about their child’s illness (OR = 1.59, 95% CI = 1.06, 2.39) and 
altruism (OR = 3.64, 95% CI = 2.20, 6.02) was also associated with higher participation, while 
vii 
concern about the nose and throat swab (OR = 0.48, 95% CI = 0.36, 0.65) was associated with 
lower participation. These findings show clinical presentation of CAP does not adequately 
predict LOS, while parent-reported markers of a child’s physical function may predict LOS. 
Detailed explanation of potential benefits and reducing invasive procedures could improve 
participation in research. 
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Chapter 1 Introduction 
Community-acquired pneumonia (CAP) is a leading cause of hospitalization among 
children under 18 years of age in the United States,1 and ranks third among leading causes of 
pediatric hospitalization outside the neonatal period.2 There is evidence of wide-variation in 
pediatric community acquired pneumonia CAP-related admissions rates as documented in 
previous studies. One such study, conducted by Gorton in 2006,2 found high levels of variation 
among county rates of hospitalization in Pennsylvania. In this study, the annual rates of 
hospitalization ranged from 18.3 per 100,000 to 350.3 per 100,000.3  This is also acknowledged 
in the current clinical guidelines for CAP (referred to as clinical guidelines) published by 
Bradley in 2011,4 (Bradley et al “The management of community-acquired pneumonia in infants 
and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious 
Disease Society and the Infectious Disease Society of America”). “The wide variation in CAP-
related admission rates between neighboring geographic regions2 suggests that physicians do not 
use consistent criteria to make site-of-care decisions.”3 These findings suggest the need for better 
ways to help physicians make decisions pertaining to the appropriate site-of-care and 
acknowledge an important gap in the clinical guidelines resulting from the lack of this 
information. 
This research project comprises three discrete, albeit interrelated, studies of children with 
CAP. The project uses data collected for the Centers for Disease Control and Prevention’s 
(CDC) Etiology of Pneumonia in the Community (EPIC) study. The first study aims to examine 
factors associated with one type of potentially unnecessary hospitalization, as defined by a length 
of stay (LOS) in the hospital for ≤ 24 hours for children hospitalized with CAP. The second 
study aims to validate the Canadian Acute Respiratory Illness and Flu Scale (CARIFS) 
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questionnaire among an inpatient pediatric population with CAP. Furthermore, this study will 
examine the utility of the CARIFS instrument in predicting LOS, measured by days in the 
hospital. The CARIFS data were collected as part of the EPIC study. Finally, a third set of data 
from the EPIC study will be utilized to examine factors that influence parental consent for their 
child to participate in epidemiological research. This will be done by comparing parental 
attitudes toward motivational factors among study participants with those who refused to 
participate. 
The EPIC study 
The EPIC study is a prospective, population-based study that was conducted to determine 
the incidence and etiology of hospitalized CAP in children and adults in the U.S.5 The study was 
conducted from January 2010-June 2012 at three pediatric sites: Le Bonheur Children's Hospital 
in Memphis, the Monroe Carell Jr. Children's Hospital at Vanderbilt in Nashville and the 
Primary Children's Hospital in Salt Lake City.5 These analyses only address the pediatric study 
subjects. Three thousand eight hundred and three children, up to the age of 18, were identified as 
eligible for the study and 2,638 (69%) were enrolled.5  As a part of the EPIC study, key clinical, 
socioeconomic, and demographic information was collected through caregiver interviews and 
medical record review. Detailed methodology for EPIC is described elsewhere.5 
In this project, data from the EPIC study will be used to identify factors associated with a 
mild course of pneumonia among children who were hospitalized, as indicated by discharge from 
the hospital within ≤ 24 hours. 
The CARIFS survey 
CARIFS is a caregiver questionnaire that assesses the parent’s perceived functional 
burden of illness related to acute respiratory disease in their child according to three domains of 
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illness: 1) physical symptoms, 2) the child’s function, and 3) impact on the parents’ daily 
routine.6 The questionnaire was designed through a joint effort between parents and pediatricians 
to ensure that the questions reflect signs and symptoms that are important to both groups. 
CARIFS was originally designed to meet the need for an objective outcome measure of disease 
severity among children with acute respiratory infections. It has been validated for use among 
children treated in outpatient settings such as physician practices7 but not, to our knowledge, 
among children who are hospitalized with pneumonia.  
CARIFS may prove to be a valid tool for evaluating disease severity, as measured by 
LOS, among children hospitalized with CAP. Furthermore, it may provide additional information 
on determinants of unnecessary hospitalization for children with CAP. The CARIFS survey was 
completed upon admission into the EPIC study by a parent or caregiver. For this project, data 
from CARIFS will be used to assess the validity of the CARIFS instrument among inpatient 
children with CAP, and examine its utility in predicting LOS in this patient population. 
The Parental Research Consent Survey 
Engagement of all eligible subjects to participate in research studies ensures the benefits 
of research to all regardless of age, sex, socioeconomic status, race or ethnicity and health status. 
Additionally, a high participation rate is important to ensure the study sample mirrors the entire 
patient population and decreases the effects of selection bias on the results. Recent reports 
suggest that participation rates for epidemiologic studies have been declining over the past 30 
years.8 Patients who participate in research studies must not only meet the inclusion criteria, as 
defined by the study protocol, but then agree to participate after receiving information about 
possible risks and potential benefits (informed consent). Subject participation can be enhanced 
through a focus on factors that influence parents’ decisions to allow their child to participate in 
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research studies. This project is designed to identify those factors using data from the EPIC 
study. This is important because it can guide the development of targeted communications that 
facilitate the recruitment of all study participants including those in under-represented 
demographic populations. 
Each of the three studies will be described, in its own chapter, beginning with the study 
that examined factors associated with potentially unnecessary hospitalizations in Chapter Two. 
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Chapter 2 Assessing Factors Associated with Potentially Unnecessary Hospitalization of 
Children with CAP 
Background and Significance 
Community-acquired pneumonia (CAP) is a leading cause of hospitalization among 
children under 18 years of age in the United States1 and results in approximately 375,000 
emergency departments (ED) visits and 155,000 hospitalizations each year.9 CAP ranks third 
among leading causes of pediatric hospitalization outside the neonatal period.2 There are 
differences in hospital utilization by age. One study reported an overall rate of 201.2 CAP-
related hospitalizations per 100,000 in 2006.7 Children less than one year of age had the highest 
rate, 912.9 per 100,000; those one to five years of age, 390.4 per 100,000; those six to twelve 
years of age, 84.5 per 100,000, and those 13 to 18 years of age had a rate of 62.8 per 100,000.1  
Interestingly, there is also wide variation in the proportion of children with CAP who are 
hospitalized across the US. A study of more than 1,000,000 ED encounters in 35 pediatric 
hospitals across the US found that admission rates for pneumonia ranged from 17-69 percent.10 
Pneumonia was one of seven common conditions that were studied including: asthma, 
bronchiolitis or respiratory syncytial virus (RSV), kidney disease and urinary tract infection 
(UTI), concussion, cellulitis or bacterial skin infections, pneumonia, and seizure; the amount of 
range in hospitalization for pneumonia was second only to concussion, which had a variance of 
5-72 percent.10 This variation, which was largely independent of population differences or 
disease severity, is evidence of a lack of sufficient guidelines to help determine who needs to be 
hospitalized, and indicates a need for better strategies to proactively identify children who need 
hospitalization.10  
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Typically, the need for hospitalization of patients with CAP is determined by an ED 
physician based on clinical assessment and guidelines. Clinical guidelines are “systematically 
developed statements to assist practitioners and patients in making decisions about appropriate 
health care for specific clinical circumstances.”11 However, guidelines require clinical evidence 
upon which to make recommendations. In the absence of adequate evidence, expert opinion is 
used. 
Clinical guidelines for pediatric CAP 
The current clinical guidelines for pediatric CAP were published by Bradley et al in 
20114 and provide guidance on when infants and children in the U.S. need to be hospitalized.  
According to the guidelines, hospitalization is recommended for the cases of CAP that 
present in respiratory distress (see Figure 1) that includes the following: 
1. Children and infants who have moderate to severe CAP as defined by several factors, 
including respiratory distress and hypoxemia (sustained SpO2, <90 % at sea level) . . . should 
be hospitalized for management including skilled pediatric nursing care. (strong 
recommendation; high-quality evidence) 
2. Infants <3–6 months of age with suspected bacterial CAP are likely to benefit from 
hospitalization. (strong recommendation; low-quality evidence) 
3. Children and infants with a suspicion or documentation of CAP caused by a pathogen 
with increased virulence, such as CA-MRSA, should be hospitalized. (strong 
recommendation; low-quality evidence) 
4. Children and infants for whom there is concern about careful observation at home or 
who are unable to comply with therapy or unable to be followed up should be hospitalized. 
(strong recommendation; low-quality evidence) 
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Figure 1. Criteria for Respiratory Distress in Children with Pneumonia4 
 
The clinical guidelines also note young age, dehydration, comorbid conditions, vomiting 
or inability to take oral medications, and psychosocial concerns as additional considerations for 
hospitalization. Psychosocial concerns may represent concern for parental noncompliance with 
therapy or limited access to follow-up care. 
“Furthermore, those with psychosocial concerns, such as noncompliance with therapy or lack 
of reliable follow-up for any reason, may warrant admission. Studies from both the United 
States and Canada found that children and infants with pneumonia were more likely to be 
hospitalized if they were of lower socioeconomic status. This may be attributed, in part, to 
nonmedical issues, including inaccessibility to adequate outpatient services.”4 
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The clinical guidelines also note the need for a scoring system, as is present in the adult 
realm, to determine whether or not a child with CAP needs to be hospitalized as most of the 
aforementioned recommendations, while strong, were based on low quality evidence. 
“In the past few decades, many consensus guidelines and clinical decision rules have been 
proposed for adults with CAP. There are multiple adult studies that describe scoring systems 
that have been demonstrated to be useful in predicting both which adults should be 
hospitalized and which adults require intensive care. Unfortunately, these scoring systems 
have not been validated in children and do not consider pediatric comorbid conditions, 
developmental stage, or psychosocial factors that influence the treating clinician’s decision 
on the site of treatment for pediatric patients with CAP.”4 
 Clinical decision rules for adults with CAP 
Clinical decision rules are tools that aid in facilitating patient management decisions 
based on the patient’s level of risk. Among adults, tools like the CURB-65 (confusion, urea, 
respiratory rate, and blood pressure)12 and the Pneumonia Severity Index (PSI)13 were developed 
for patients with CAP. These tools are currently being used in clinical practice, and several 
published studies indicate that their use is associated with reduced hospitalization among low 
risk individuals.14 The adult models, however, have not been validated in children because they 
lack factors that are specific to children. The adult models do not consider pediatric comorbid 
conditions, developmental stage, or psychosocial factors that influence the treating clinician’s 
decision on the site of treatment for pediatric patients with CAP.4 Additionally, the adult models 
are based on the patient’s risk of death, which is rare in children and not a useful outcome 
measure for guiding treatment decisions in pediatric patients with CAP.3  
A clinical decision rule for pediatric CAP, noted as a need in the current clinical 
guidelines,4 would assist physicians with determining the need for hospitalization in children 
with CAP, and could result in the reduction of precautionary hospitalizations. This is important 
because hospitalization, for children, is intrusive and may have physical and emotional effects 
that extend beyond their time in the hospital. Keeping children out of the hospital, when 
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hospitalization isn’t necessary, will not only reduce the large financial burden of pediatric CAP, 
but, more importantly, will protect the children from additional adverse health outcomes such as 
healthcare-acquired infections and exposure to radiation and families from the stresses of 
hospitalizations such as missed work and need for child care. A better understanding of factors 
associated with mild cases of CAP will provide physicians with better information to determine 
the patients who can be treated safely at home. The abundant information that was collected as 
part of the EPIC study provides a unique opportunity to assess factors related to decisions of 
hospitalization.  
The purpose of the proposed research is to identify factors associated with a mild course 
of pneumonia, as indicated by discharge from the hospital ≤ 24 hours, among children who are 
hospitalized. The factors that we studied are mainly related to factors identified in the clinical 
guidelines and easily assessed in the ED. A clear understanding of the association of these 
factors to a mild course of pneumonia, is the first step in designing and implementing effective 
counter strategies for reducing unnecessary hospitalizations among children with CAP. The 
ultimate goal is to provide evidence for developing guidelines for managing pediatric pneumonia 
to reduce the number of unnecessary hospitalizations.  
Methods 
The EPIC study is a prospective, population-based study that was conducted to determine 
the incidence and etiology of children with CAP who required hospitalization in the U.S. From 
January 1, 2010, to June 30, 2012. Children up to the age of 18 years of age, were enrolled in the 
EPIC study at three large pediatric hospitals across the country: Le Bonheur Children’s Hospital 
(LBCH) in Memphis, TN, Monroe Carell Jr. Children’s Hospital at Vanderbilt in Nashville, TN, 
and Primary Children’s Hospital in Salt Lake City, UT.5 Investigators sought to enroll all eligible 
10 
children; therefore, trained staff screened children for enrollment at least 18 hours per day, seven 
days per week. Written informed consent was obtained from parents or caregivers before 
enrollment, with children providing assent when age appropriate. The study protocol was 
approved by the institutional review board at each institution and at the CDC. Weekly study 
teleconferences, required weekly enrollment reports, data audits, and annual study-site visits 
were conducted to ensure uniform procedures among the study sites. Study coordinators who 
collected the study data were trained in a standard fashion and conducted all consent and parent 
interviews.5  
Inclusion/Exclusion criteria 
Children were included in the study if they were admitted to one of the three study 
hospitals; resided in one of the counties in the study catchment areas; had evidence of acute 
infection (defined as reported fever or chills, documented fever or hypothermia, leukocytosis or 
leukopenia in conjunction with respiratory symptoms); had evidence of an acute respiratory 
illness (defined as new cough or sputum production, chest pain, dyspnea, tachypnea, abnormal 
lung examination, or respiratory failure), and had evidence consistent with pneumonia as 
assessed by means of chest radiography within 72 hours of admission.5  
Children were excluded if they were not enrolled into the study within 72 hours of 
admission or declined participation, had been hospitalized recently (<7 days for 
immunocompetent children and <90 days for immunosuppressed children), had been enrolled in 
the EPIC study within the previous 28 days, resided in an extended-care facility, or were 
newborns who never left the hospital. Children were also excluded if they had a tracheostomy 
tube, if they had cystic fibrosis or cancer with neutropenia, if they had received a solid-organ or 
hematopoietic stem-cell transplant within the previous 90 days, if they had active graft-versus-
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host disease or bronchiolitis obliterans or if they had human immunodeficiency virus (HIV) 
infection with a CD4 cell count of less than 200 per cubic millimeter (or a percentage of CD4 
cells <14%). Children with a clear alternative non-pneumonia diagnosis were also excluded. 
Final determination of inclusion in the study required independent confirmation by the board-
certified pediatric study radiologist at each study hospital; these radiologists (all of whom are co-
investigators in the study) were blinded to the patients’ demographic and clinical information.5 
Radiographic evidence of pneumonia was defined as the presence of consolidation (a dense or 
fluffy opacity with or without air bronchograms), other infiltrate (linear and patchy alveolar or 
interstitial densities), or pleural effusion.15 
Study sample 
Participants included children, up to the age of 18, with respiratory illness who were 
admitted to LBCH between January 2010 and June 2012 and participated in the EPIC study.5 
Figure 2 shows a flowchart of the EPIC study. There were adequate sample sizes for each of the 
age groups. Two hundred seventy four patients were included in the youngest age group, zero to 
five months old; 781 in the six to twenty three month age group; 595 in the two to four year old 
age group; 422 in the five to nine year old age group and 286 in the ten to eighteen year old age 
group.   
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Figure 2. Consort diagram of the EPIC Study. 
 
Study variables 
Variables included in this study are typically associated with respiratory illness in 
children. They are easily assessed in the ED and potentially help in determining the need for 
hospitalization among children seen in the ED.  
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Outcome variable. A LOS in the hospital, measured in hours between time of decision 
to admit and leaving the hospital, dichotomized as ≤24 hours and > 24 hours. For the purpose of 
this study, a LOS ≤ 24 hours is considered an indicator of unnecessary hospitalization. 
Main independent variables. The following clinical factors, which are routinely 
ascertained in the ED, will be evaluated: tachypnea, respiratory rate, dyspnea (see Figure 1), 
intercostal retraction, altered mental status, oxygenation, fever, chills hypothermia 
vomiting/nausea, wheezing, heart rate, age-specific systolic blood pressure, and asymmetric 
breath sounds.   
Covariates. Based on published literature and clinical and epidemiological plausibility, 
other covariates include: age, gender, race, and health insurance status. Table 1 illustrates the 
independent variables and covariates that are used in this analysis. 
 
Table 1. Description of study variables 
 
Variable Description 
Fever History during this illness (Y/N) 
Chills History during this illness (Y/N) 
Nausea History during this illness (Y/N) 
Wheezing Existence of (Y/N)  
Confusion Existence of (Y/N) 
Respiratory rate  Breaths per minute (at presentation) 
Heart rate  Beats per minute (at presentation) 
Systolic blood pressure  mmHg (at presentation) 
Oxygen saturation  Percent (at presentation) 
Temperature  Degrees Fahrenheit (at presentation) 
Intercostal retraction History during this illness (Y/N) 
Decreased breath sounds Existence of (Y/N) 
Age of the child Months 
Child’s gender  Male/Female 
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Table 1 (Continued)  
Variable Description 
Child’s race  
Non-Hispanic black, non-Hispanic white, Hispanic, 
multiracial, other 
Health insurance Public, private, none  
 
Analysis 
Demographic characteristics of participants were summarized by five age groups zero to 
five months, six to twenty three months, two to four years, five to nine years, and ten to eighteen 
years. They included gender race and type of insurance (Table 2).  
Logistic regression was used to evaluate bi-variable associations between independent 
clinical and demographic variables and the study outcome variable (LOS ≤ 24 hours and >24 
hours). Clinical variables with a significance level of 0.3 and less were included in the 
multivariable models. The less stringent level of 0.3 was used to ensure the inclusion of all 
potentially important clinical variables due to the exploratory nature of the study. 
Multivariable logistic regression was performed to assess the adjusted associations of 
demographic and clinical factors with the study outcome. Variables identified from the bi-
variable analyses were entered into the model and they were removed, one at a time, based on 
the largest significance level, using the stepwise backward elimination method.  Variables with a 
significance level of 0.05 were retained in the model. All bi-variable and multivariable analyses 
were performed within each age category. For the multivariable logistic modelling, collinearity 
between variables was also assessed. Variation Inflation Factors (VIF) values for a variable over 
three indicated multicollinearity. All analyses were conducted with SPSS version 24 (IBM).16 
Tests of statistical significance were two sided, with an alpha level of 0.05, and are reported with 
three significant digits. 
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Results 
Of 3,803 eligible children, 2,638 (69.4%) were enrolled between January 2010 and June 
2012; 2,358 (89.4%) are included in this study. Just over half, 54.7% (n=1,291) were boys and 
45.3% (n=1,067) were girls. Sixty two percent (n=1,468) had public insurance, 35.8% (n=843) 
private insurance, and 1.6% (n=38) had no insurance. The racial breakdown was 39.8% (n=939) 
white, 33.1% (n=781) black, 19.2% (n=452) Hispanic, and 7.5% (n=176) other. The percent of 
patients with a household education level less than a high school degree was 11.8% (n=278), 
high school graduate 28.3% (n=667), some college 24.2% (n=571), and a college degree or more 
29.1% (n=687). Twenty two percent of the participants (n=515) were hospitalized for 24 hours 
or less and 78.2% (n=1.843) were hospitalized for more than 24 hours. This was consistent 
across age groups (Figure 3). The missing data for each of the factors ranged from 0.4% to 6.5%. 
Table 2 shows the study sample characteristics by age category. 
 
Table 2. Demographic characteristics of the EPIC study population, by age group 
 
Age Group 0-5 months 6-23 months 2-4 years 5-9 years 10-18 years 
    N (%) N (%) N (%) N (%) N (%) 
Race White 105 (38.3) 239 (30.6) 242 (40.7) 196 (46.4) 157 (54.9) 
  Black 76 (27.7) 275 (35.2) 209 (35.1) 138 (32.7) 83 (29.0) 
  Hispanic 64 (23.4) 194 (24.8) 99 (16.6) 58 (13.7) 37 (12.9) 
  Other 29 (10.6) 70 (9.0) 41 (6.9) 28 (6.6) 8 (2.8) 
  Missing 0 (0.0) 3 (0.4) 4 (0.7) 2 (0.5) 1 (0.3) 
  Total 274 (100.0) 781 (100.0) 595 (100.0) 422 (100.0) 286 (100.0) 
Gender Male 160 (58.4) 436 (55.8) 301 (50.6) 244 (57.8) 150 (52.4) 
  Female 114 (41.6) 345 (44.2) 294 (49.4) 178 (42.2) 136 (47.6) 
  Total 274 (100.0) 781 (100.0) 595 (100.0) 422 (100.0) 286 (100.0) 
Insurance Public 199 (72.6) 567 (72.6) 384 (64.5) 210 (49.8) 108 (37.8) 
  Private 72 (26.3) 201 (25.7) 198 (33.3) 201 (47.6) 171 (59.8) 
  None 3 (1.1) 11 (1.4) 8 (1.3) 9 (2.1) 7 (2.4) 
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Table 2 (Continued) 
Age Group 0-5 months 6-23 months 2-4 years 5-9 years 10-18 years 
    N (%) N (%) N (%) N (%) N (%) 
  Missing 0 (0.0) 2 (0.3) 5 (0.8) 2 (0.5) 0 (0.0) 
  Total 274 (100.0) 781 (100.0) 595 (100.0) 422 (100.0) 286 (100.0) 
 
Bi-variable Regression 
Tables 3-7 show the results of the bi-variable analyses by each age category.  
A higher respiratory rate and heart rate were associated with a longer length of stay, and a 
high oxygen saturation level was associated with a LOS ≤ 24 hours. Increasing age was 
associated with a LOS of 24 hours or less.  History of wheezing, chills and retraction were not 
associated with LOS. Variables in bold font were included in the multivariable models. 
 
Table 3. Unadjusted odds ratios of the associations of study variables with length of stay (≤24 
hours) for age group 0-5 months (n=274) 
 
Variable OR 95% CI P 
Fever (history) 2.15 0.73 6.36 0.166 
Confusion 0.63 0.08 5.08 0.665 
Wheezing 0.78 0.38 1.56 0.477 
Nausea 1.40 0.69 2.85 0.355 
Chills 0.56 0.19 1.67 0.301 
Retraction 1.27 0.63 2.57 0.505 
Breathing 0.71 0.26 1.91 0.493 
Oxygen Saturation (%) 1.11 1.02 1.21 0.017 
Heart Rate (beats/min) 0.97 0.95 0.98 <0.001 
Respiratory Rate (per minute) 0.98 0.96 1.00 0.060 
Systolic Blood Pressure 1.00 0.97 1.02 0.891 
Temperature 0.96 0.79 1.16 0.652 
age (months) 1.47 1.16 1.87 0.001 
Patient Gender (ref is Male) 0.64 0.31 1.33 0.226 
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Table 3 (Continued)     
Variable OR 95% CI  P 
Insurance (ref is Public)     
  Private 1.61 0.77 3.36 0.207 
  None 0.00 0.00 0.00  0.999 
Race (ref is White)     
Black 0.49 0.19 1.24 0.132 
  Hispanic 0.90 0.39 2.08 0.797 
  Other 0.36 0.08 1.64 0.186 
 
 
Table 4. Unadjusted odds ratios of the associations of study variables with length of stay (≤ 24 
hours) for age group 6-23 Months (n=781) 
 
Variable OR 95% CI P 
Fever 1.14 0.54 2.41 0.732 
Confusion 0.50 0.23 1.07 0.074 
Wheezing 0.72 0.51 1.02 0.063 
Nausea 0.80 0.56 1.12 0.190 
Chills 1.12 0.76 1.65 0.563 
Retraction 0.61 0.43 0.87 0.006 
Breathing 0.95 0.65 1.39 0.790 
Oxygen Saturation (%) 1.06 1.02 1.09 0.001 
Heart Rate (beats/min) 1.00 0.99 1.01 0.559 
Respiratory Rate (per minute) 0.983 0.97 1.00 0.004 
Systolic Blood Pressure 0.999 0.99 1.01 0.802 
Temperature 0.992 0.92 1.08 0.844 
age (months) 1.032 1.00 1.07 0.073 
Patient Gender (ref is Male) 1.286 0.91 1.81 0.153 
Insurance     
  Private 0.96 0.64 1.42 0.819 
  None 2.13 0.61 7.39 0.234 
Race (ref is White)     
  Black 0.49 0.19 1.24 0.132 
  Hispanic 0.90 0.39 2.08 0.797 




Table 5. Unadjusted odds ratios of the associations of study variables with length of stay (≤ 24 
hours) for age group 2-4 Years (n=595) 
 
Variable OR 95% CI P 
Fever (history) 0.67 0.31 1.43 0.297 
Confusion 1.00 0.98 1.01 0.705 
Wheezing 0.77 0.52 1.13 0.182 
Nausea 0.70 0.48 1.03 0.067 
Chills 0.83 0.56 1.24 0.367 
Retraction 1.11 0.76 1.63 0.596 
Breathing 0.8 0.54 1.17 0.248 
Oxygen Saturation (%) 1.06 1.02 1.10 0.004 
Heart Rate (beats/min) 1.00 1.00 1.01 0.424 
Respiratory Rate (per minute) 0.99 0.97 1.00 0.051 
Systolic Blood Pressure 0.99 0.98 1.01 0.300 
Temperature 0.99 0.90 1.09 0.856 
Age 1.01 0.99 1.03 0.583 
Patient Gender (ref is Male) 1.30 0.88 1.90 0.185 
Insurance     
  Private 1.19 0.80 1.79 0.393 
  None 0.52 0.06 4.27 0.541 
Race (ref is White)     
  Black 1.07 0.69 1.66 0.764 
  Hispanic 0.92 0.52 1.62 0.760 
  Other 1.10 0.51 2.38 0.815 
 
 
Table 6. Unadjusted odds ratios of the associations of study variables with length of stay (≤ 24 
hours) for age group 5-9 Years (n=422) 
 
Variable OR 95% CI P 
Fever (history) 2.59 1.07 6.28 0.035 
Confusion 0.26 0.03 2.00 0.194 
Wheezing  0.77 0.49 1.20 0.245 
Nausea 1.88 1.19 2.97 0.007 
Chills 1.25 0.81 1.95 0.313 
Retraction 1.20 0.77 1.89 0.420 
Breathing 1.39 0.88 2.21 0.163 
Oxygen Saturation (%) 1.05 1.01 1.10 0.030 
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Table 6 (Continued)     
Variable OR 95% CI P 
Heart Rate (beats/min) 0.99 0.98 1.00 0.086 
Respiratory Rate (per minute) 0.99 0.97 1.01 0.199 
Systolic Blood Pressure 1.00 0.98 1.02 0.977 
Temperature 1.01 0.90 1.14 0.829 
Age 1.00 0.99 1.01 0.806 
Patient sex 0.77 0.49 1.20 0.245 
Insurance (ref is Public)     
  Private 0.93 0.60 1.46 0.755 
  None  2.31 0.60 8.92 0.224 
Race (ref is White)     
  Black 0.99 0.98 1.00 0.086 
  Hispanic  0.99 0.97 1.01 0.199 
  Other 1.00 0.98 1.02 0.977 
 
 
Table 7. Unadjusted odds ratios of the associations of study variables with length of stay (≤ 24 
hours) for age group 10-18 Years (n=286) 
 
Variable OR 95% CI P 
Fever (history) 2.15 0.62 7.51 0.228 
Confusion 0.78 0.37 1.66 0.521 
Wheezing 1.00 0.58 1.71 0.991 
Nausea 0.73 0.42 1.25 0.249 
Chills 1.22 0.69 2.14 0.49 
Retraction 0.75 0.40 1.42 0.378 
Breathing 0.98 0.56 1.70 0.927 
Oxygen Saturation (%) 1.13 1.05 1.22 0.001 
Heart Rate (beats/min) 0.99 0.97 1.00 0.058 
Respiratory Rate (per minute) 0.96 0.93 0.99 0.013 
Systolic Blood Pressure 1.02 1.00 1.04 0.070 
Temperature (Fahrenheit) 1.13 0.97 1.31 0.117 
Age 1.00 0.99 1.01 0.552 
Gender 1.43 0.83 2.46 0.195 
Insurance (ref is Public)     
  Private 0.87 0.50 1.52 0.631 
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Table 7 (Continued)     
Variable OR 95% CI P 
  None  1.14 0.21 6.23 0.877 
Race (ref is White)     
  Black 0.84 0.44 1.58 0.585 
  Hispanic 1.28 0.58 2.83 0.541 




Figure 3. Study length of stay (≤ 24 hours and > 24 hours) for EPIC participants, by age group 
 
Multivariable Regression 
Tables 8–12 show factors potentially associated with a LOS ≤ 24 hours. Higher oxygen 
saturation level at presentation was consistently associated with a LOS of 24 hours or less across 
all age groups. Among those under six months old, as age increased the chances of having a LOS 
of 24 hours or less increased indicating residual confounding by age. A history of fever, chills, 
respiratory rate, patient gender, insurance, and race were not associated with LOS. The VIF did 




Table 8. Adjusted odds ratios of factors associated with length of stay in age group 0-5 months 
 
Variable OR 95% CI P 
Heart Rate 0.97 0.95 0.99 0.001 
Oxygen Saturation (%) 1.12 1.02 1.23 0.022 
Age (months) 1.45 1.13 1.87  0.004 
 
Table 9. Adjusted odds ratios of factors associated with length of stay in age group 6-23 months 
 
Variable OR 95% CI P 
Oxygen Saturation (%) 1.06 1.02 1.09 0.001 
 
Table 10. Adjusted odds ratios of factors associated with length of stay in age group 2-4 years  
 
Variable OR 95% CI P 
Nausea  0.65 0.45 0.98 0.033 
Oxygen Saturation (%) 1.0 6 1.02 1.11 0.003 
 
Table 11. Adjusted odds ratios of factors associated with length of stay in age group 5-9 years  
 
Variable OR 95% CI P 
Nausea 1.96 1.23 3.12 0.005 
Oxygen Saturation (%) 1.05 1.00 1.10 0.050 
 
Table 12. Adjusted odds ratios of factors associated with length of stay in age group 10-18 years  
 
Variable OR 95% CI P 
Oxygen Saturation (%) 1.13 1.05 1.22 0.001 
 
Discussion 
Using data from a large prospective study of pediatric community-acquired pneumonia 
hospitalizations in the U.S., we examined variables associated with potentially unnecessary 
hospitalizations among different age groups of children with pneumonia. The ultimate goal, 
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which wasn’t achieved, was to provide evidence for developing guidelines for managing 
pediatric pneumonia to reduce the number of unnecessary hospitalizations. 
LOS, among our study population is consistent with other studies in the literature. In our 
sample the mean LOS for the entire groups was 3.92 (± 3.77). Our study found that the youngest 
children had longer hospitalization, 5.49 (±4.66) indicating a greater severity which is consistent 
with previous studies.1   
Our finding of the association between a higher oxygen saturation level and LOS ≤ 24 
hours is consistent with the clinical guidelines.3 Oxygen saturation level is the only one high-
quality recommendation for hospitalization from the clinical guidelines.  
Asthma is potentially an important confounder. Thirty percent of the children in this 
study had a history of asthma. This is less than the findings of a national study that was 
conducted among 17,299 pediatric pneumonia cases in 125 hospitals across the U.S. In that 
study, they found 42% of the children had a history of asthma.17 The majority of children in our 
sample, (70%) in each age group, with asthma were hospitalized more than 24 hours. We 
evaluated the relationship between asthma and LOS and found that it was not associated with a 
LOS ≤ 24 hours among this population.  
A strength of our study is that it was conducted with data from three large children’s 
hospitals in the U.S. While this sample is large, and somewhat diverse, it is limited to children 
who were seen in children’s hospitals in only two states across the country. As a result, these 
findings may not be consistent among other patient populations across the U.S.  
Limitation 
A limitation of our study is misclassification of historical subjective clinical factors that 
were obtained through parental interview. One example is nausea.  
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Conclusion 
 Developing guidelines for more consistent management of pediatric CAP may reduce the 
number of potentially unnecessary hospitalizations and is an important clinical advancement. 
Our data suggest that the percent of oxygen saturation may be a strong indicator of LOS in all 
ages and is important to consider for future models.  
 Further prospective studies are needed, preferably designed specifically for each age-
group, to identify the age-specific factors related to potentially unnecessary hospitalizations, 
including relevant co-morbidities.  
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Chapter 3 Evaluation of the Canadian Acute Respiratory Illness and Flu Scale 
(CARIFS) as a Predictor of Length of Stay among Pediatric Inpatients with CAP  
Background and significance 
Community-acquired pneumonia (CAP), a common and potentially serious infection in 
childhood, affects approximately three million children and is a leading cause of hospitalization 
among children under 18 years old in the United States.1 CAP accounts for >200,000 
hospitalizations each year in the United States,18 with an estimated cost for hospitalizations of 
approximately three billion dollars in 2009.2 Despite this large disease burden, critical gaps in 
our knowledge about the appropriate course of care for children with CAP remain.  
These gaps in knowledge are due, in part, to the difficulty measuring the severity of the 
disease as noted in the current clinical guidelines. These guidelines, referred to as clinical 
guidelines, (Bradley, 2011 “The management of community-acquired pneumonia in infants and 
children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious 
Diseases Society and the Infectious Diseases Society of America”)4 express a need for better 
ways to assess disease severity among children with CAP.”  A potential tool for measuring 
disease severity among an inpatient pediatric population with CAP is the Canadian Acute 
Respiratory Illness and Flu Scale (CARIFS).6 
The CARIFS survey, comprised of 18 questions, was originally designed to measure 
disease severity among children with acute respiratory illness, in outpatient areas such as 
physician practices.6 CARIFS is completed by the parent of the child and assesses disease 
severity according to three conceptual domains of illness: clinical symptoms, physical function, 
and items that impact the parent. It has been used to evaluate the treatment effectiveness of 
antibiotics and other antimicrobial agents.6;7 
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The three domains are comprised of multiple items or questions. Items in the clinical 
symptoms domain include: headache, sore throat, muscle aches, fever, cough, nasal congestion 
and vomiting. The function domain includes: poor appetite, disrupted sleep, irritability, feeling 
unwell, low energy, not playing well, excessive crying. The parental impact domain includes: the 
need for extra care, clinginess, not interested in what’s going on and unable to get out of bed. 
Each question in the survey is graded on a four-point scale that measures the level of severity.  
CARIFS was evaluated, in a study of 206 children with acute respiratory illness, utilizing 
data from the outpatient clinics at The University of Toronto. To assess construct validity, the 
CARIFS scores were compared between the physician, nurse and parental assessment of the of 
the child’s health. Correlations between the parental assessment and the physician assessment 
and the parental assessment and the nurses assessment were weak, Spearman correlation 
coefficients were 0.30 and 0.28 respectively.4  
To our knowledge, the CARIFS scale has not been evaluated in an inpatient setting. The 
instrument, however, may prove to be a useful tool for evaluating disease severity among 
pediatric patients hospitalized with CAP. This is important because it may provide additional 
information to help physicians determine the appropriate LOS in the hospital. This may lead to a 
reduction of days in the hospital among children with CAP.  
The purpose of this study is to assess the validity of the CARIFS instrument among 
inpatient children with CAP, and examine its utility in predicting LOS in this patient population, 
using data collected by the CARIFS instrument as a supplemental part of the EPIC study.  
Methods 
The18 items in the CARIFS instrument are graded on a four-point Likert scale. Response 
options include: no problem, minor problem, moderate problem, major problem and don’t know 
26 
or not applicable. The instrument was completed by the parent with the assistance of a trained 
study assistant.  
Study sample 
Children under the age of 18 years with respiratory illness who were admitted to LBCH 
between January 2010 and June 2012 and participated in the EPIC study.  
Inclusion/Exclusion criteria  
Children were  included in the study if they were admitted to Le Bonheur Children’s 
Hospital; resided in one of the counties in the study catchment areas; had evidence of acute 
infection (defined as reported fever or chills, documented fever or hypothermia, leukocytosis or 
leukopenia in conjunction with respiratory symptoms); had evidence of an acute respiratory 
illness (defined as new cough or sputum production, chest pain, dyspnea, tachypnea, abnormal 
lung examination, or respiratory failure), and had evidence consistent with pneumonia as 
assessed by means of chest radiography within 72 hours before or after admission. A caregiver 
had to complete the CARIFS survey upon admission.5 
Children were excluded if they were not enrolled into the study within 72 hours of 
admission or declined participation, had been hospitalized recently (<7 days for 
immunocompetent children and <90 days for immunosuppressed children), had been enrolled in 
the EPIC study within the previous 28 days, resided in an extended-care facility, or were 
newborns who never left the hospital. Children were also excluded if they had a tracheostomy 
tube, if they had cystic fibrosis or cancer with neutropenia, if they had received a solid-organ or 
hematopoietic stem-cell transplant within the previous 90 days, if they had active graft-versus-
host disease or bronchiolitis obliterans or if they had human immunodeficiency virus (HIV) 
infection with a CD4 cell count of less than 200 per cubic millimeter (or a percentage of CD4 
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cells <14%). Children with a clear alternative non-pneumonia diagnosis were also excluded. 
Final determination of inclusion in the study required independent confirmation by the board-
certified pediatric study radiologist at each study hospital; these radiologists (all of whom are 
coauthors of the study) were blinded to the patients’ demographic and clinical information.5 
Radiographic evidence of pneumonia was defined as the presence of consolidation (a dense or 
fluffy opacity with or without air bronchograms), other infiltrate (linear and patchy alveolar or 
interstitial densities), or pleural effusion.15 Those who did not complete the CARIFS survey 
within 48 hours of admission were excluded. 
Study variables 
The outcome variable is LOS, defined as number of days in the hospital. Main 
independent variables include factors that were identified through factorial analysis that was 
conducted with the 18 CARIFS questions. Covariates include age, gender, race, highest level of 
household education, and type of insurance. Table 13 shows the variables used in the study. 
 
Table 13. Definition of independent variables used in the CARIFS study 
 
Variable name Definition 
Demographic Variables 
Age of child In months 
Gender of child Male/Female 
Race of the child White, Black, Hispanic, and other 
Insurance type Public, private, and none 
Physical Function Domain 
Poor appetite 
4-point Likert scale; no problem, minor problem, moderate 
problem, major problem, don’t know/not applicable 
Not sleeping well 4-point Likert scale 
Irritable, cranky, fussy 4-point Likert scale 
Feels unwell 4-point Likert scale 
Low energy, tired 4-point Likert scale 
Not playing well 4-point Likert scale 
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Table 13 (Continued) 
Variable name Definition 
CARIFS Questions 
Excessive crying  4-point Likert scale 
Parental Impact Domain 
Needing extra care 4-point Likert scale 
Clinginess 4-point Likert scale 
No interest in what’s going on 4-point Likert scale 
Unable to get out of bed 4-point Likert scale 
Clinical Symptoms Domain 
Headache 4-point Likert scale 
Sore throat 4-point Likert scale 
Muscle aches or pains 4-point Likert scale 
Fever 4-point Likert scale 
Cough 4-point Likert scale 
Nasal congestion/runny nose 4-point Likert scale 
Vomiting 4-point Likert scale 
 
Analysis 
Participants were characterized by gender, age, race, and type of insurance. Analyses 
were subsequently stratified by age into five age groups: zero to five months, six to twenty three 
months, two to four years, five to nine years, and ten to eighteen years. The percent of questions 
not answered for each CARIFS item was evaluated by age group (Table 15). Internal reliability 
of the CARIFS instrument was evaluated overall and by each age group using Cronbach’s Alpha. 
To identify the number of domains among the 18 CARIFS survey questions, factor 
analysis, a statistical method that identifies the subthemes (latent variables) and combines survey 
questions into subsets based on response patterns, was conducted using principal axis factoring 
for extraction. Additionally, Varimax rotation was used to rotate the domains making the 
patterns more pronounced and assisting in determining the domain loadings. Themes were then 
identified for each domain.   
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Multivariable associations of independent variables with the LOS were assessed using 
generalized linear (GLM) regression models with a gamma distribution. A Gamma distribution 
was used since LOS exhibited extreme values. To evaluate the effect of the demographic factors 
on the CARIFS survey, we analyzed five models, one for each age group. Each model included 
all demographic variables and all of the factors created through the factorial analysis.  
Insurance was included in two categories, private and public; due to small numbers in 
each of the groups, Hispanic and other race was combined into other. The four domains created 
by the factor analysis were included as independent variables in the model. 
All analyses were conducted with IBM SPSS version 24 (IBM).16 Tests of statistical 




Nine hundred sixty-eight children, under the age of 18 years, were enrolled into the EPIC 
study at the LBCH site. Among these, 951 (98%) completed a CARIFS survey upon admission. 
Table 14 shows the demographic description of the study sample, by age group.  
 
Table 14. Demographic characteristics of the CARIFS study population, by age group, between 
January 2010 and June 2012 
 
Variable 0-5 months 6-23 months 2-4 years 5-9 years 10-18 years 
 N (%) N (%) N (%) N (%) N (%) 
Child’s Gender       
  Male 74 (60.2) 198 (58.4) 132 (55.5) 98 (58.3) 58 (53.2) 
  Female 49 (39.8) 141 (41.6) 106 (44.5) 70 (41.7) 51 (46.8) 
Child’s Race       
  White 33 (26.8) 41 (12.1) 39 (16.4) 32 (19.0) 31 (28.4) 
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Table 14 (Continued)      
Variable 0-5 months 6-23 months 2-4 years 5-9 years 10-18 years 
 N (%) N (%) N (%) N (%) N (%) 
  Black 73 (59.3) 247 (72.9) 178 (74.8) 115 (68.5) 70 (64.2) 
  Hispanic 15 (12.2) 37 (10.9) 9 (3.8) 12 (7.1) 7 (6.4) 
  Other  2 (1.6) 13 (3.8) 12 (5.0) 9 (5.4) 1 (0.9) 
Insurance      
  Public 101 (82.1) 296 (87.3) 194 (81.5) 103 (61.3) 57 (52.3) 
  Private 21 (17.1) 37 (10.9) 42 (17.6) 59 (35.1) 46 (42.2) 
  None 1 (0.8) 3 (0.9) 1 (0.4) 4 (2.4) 6 (5.5) 
  Both 0 (0.0) 2 (0.6) 0 (0.0) 1 (0.6) 0 (0.0) 
 
 
Table 15. Frequency of unanswered questions for each CARIFS question, LBCH EPIC study 













  N (%) N (%) N (%) N (%) N (%) 
Poor appetite 7 (5.8) 13 (3.9) 10 (4.2) 4 (2.4) 10 (9.3) 
Not sleeping well 6 (5.0) 7 (2.1) 6 (2.5) 3 (1.8) 5 (4.6) 
Irritable, cranky 6 (5.0) 9 (2.7) 4 (1.7) 1 (0.6) 5 (4.6) 
Feels unwell 10 (8.3) 12 (3.6) 4 (1.7) 2 (1.2) 5 (4.6) 
Low energy, tired 9 (7.5) 13 (3.9) 4 (1.7) 2 (1.2) 7 (6.5) 
Not playing well 22 (18.3) 14 (4.2) 6 (2.5) 4 (2.4) 11 (10.2) 
Crying more  5 (4.2) 8 (2.4) 5 (2.1) 3 (1.8) 11 (10.2) 
Needing extra care 4 (3.3) 11 (3.3) 6 (2.5) 4 (2.4) 6 (5.6) 
Clinginess 10 (8.3) 15 (4.5) 7 (3.0) 3 (1.8) 10 (9.3) 
Headache 85 (70.8) 207 (61.6) 77 (32.5) 12 (7.2) 12 (11.1) 
Sore throat 77 (64.2) 173 (51.5) 65 (27.4) 5 (3.0) 14 (13.0) 
Muscle aches  76 (63.3) 182 (54.2) 66 (27.8) 8 (4.8) 12 (11.1) 
Fever 5 (4.2) 8 (2.4) 6 (2.5) 2 (1.2) 6 (5.6) 
Cough 5 (4.2) 11 (3.3) 7 (3.0) 2 (1.2) 5 (4.6) 
Nasal congestion 3 (2.5) 10 (3.0) 3 (1.3) 1 (0.6) 6 (5.6) 
Vomiting 8 (6.7) 11 (3.3) 6 (2.5) 3 (1.8) 7 (6.5) 
No interest  26 (21.7) 22 (6.5) 8 (3.4) 2 (1.2) 9 (8.3) 
Assistance w/bed 80 (66.7) 59 (17.6) 13 (5.5) 7 (4.2) 12 (11.1) 
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Validation and evaluation of the CARIFS instrument 
Among the youngest age group, assistance with bed was not relevant and, as a result, 
nearly 70 percent of parents did not provide a response to this question. Furthermore, headaches, 
sore throat, and muscle aches are difficult to assess among children under two years old and, as a 
result, between 52 and 70 percent of parents did not provide responses to these questions, 
resulting in high percentages of missing data among 6-23 months and 2-4 years. 
Seventeen of the CARIFS items loaded on four domains. Domain one, represents 
physical function and includes: poor appetite, feels unwell, low energy/tired, not playing well, 
and assistance with bed. Domain two represents parental impact and includes: not sleeping well, 
irritable or cranky, more frequent crying, needing extra care, and clinginess. Domain three 
represents clinical variables that are not observable and domain four represent clinical symptoms 
that are observable. The assignment of each question to a domain was based on a level of 
association that was at least a 0.300. The question “No interest in what is going on” is not 
reported in Table 16 because it was less than 0.300.  
 
Table 16. The latent variables (domains) identified within the CARIFS questionnaire and the 
strength of association of each question to the domain among the LBCH EPIC population, 




One Two Three Four 
Poor appetite 0.506    
Feels unwell 0.626    
Low energy, tired 0.829    
Not playing well 0.799    
Unable to get out of bed 0.328    
Not sleeping well  0.370   
Irritable, cranky, fussy  0.673   
Excessive crying   0.699   
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Table 16 (Continued)     
Question 
Identified Domains 
One Two Three Four 
Needing extra care  0.624   
Clinginess  0.597   
Headache   0.637  
Sore throat   0.611  
Muscle aches or pains   0.682  
Fever    0.370 
Cough    0.551 
Nasal congestion/runny nose    0.643 
Vomiting    0.347 
 
 
The internal consistency of the instrument in this study population was high among all 
age groups and ranged from 0.84 to 0.90 as shown in Table 17.  
 
Table 17. Internal reliability of CARIFS questions, by age group, among the LBCH EPIC 
population, January 2010 and June 2012 
 
Age Group Cronbach’s Alpha Mean Score SD 
0-5 months 0.84 38.81 9.65 
6-23 months 0.89 40.24 12.14 
2-4 years 0.90 41.23 12.81 
5-9 years 0.88 36.29 11.58 
10-18 years 0.89 40.93 12.14 
 
 
Assessing factors associated with length of stay  
Multivariable analyses. Tables 18-22 show the results of the multivariable analyses. 
Domain one, (poor appetite, feels unwell, low energy/tired, not playing well, and assistance with 
bed) has a positive association with LOS in all age groups except for the youngest ages (zero to 
five months). Domain four (fever, cough, nasal congestion, and vomiting) is inversely associated 
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with LOS among those 2-4 years of age. Private insurance is inversely associated with LOS 
among children 6-23 months of age. Age is associated with LOS among those six months to four 
years of age. These results vary some among the different age groups indicating that the CARIFS 
survey is less effective among the youngest age group. Domain two, domain three, race and 
gender were not associated with LOS in any age group.  
 
Table 18. Multivariable logistic regression, in age group 0-5 months (n=49), LBCH EPIC 
population, between January 2010 and June 2012 
 
Variable B Std. Error 95% CI P 
Factor One 0.027 0.1604 -0.287 0.342 0.865 
Factor Two -0.120 0.1611 -0.435 0.196 0.457 
Factor Three 0.086 0.1355 -0.179 0.352 0.524 
Factor Four 0.187 0.1624 -0.132 0.505 0.250 
Race (ref is white)      
   Black  0.492 0.3290 -0.152 1.137 0.135 
   Other Race  -0.314 0.4020 -1.102 0.474 0.434 
Female child 0.152 0.2097 -0.259 0.563 0.468 
Private insurance 
(ref is public) 
-0.239 0.3920 -1.008 0.529 0.542 
Age of the child -0.057 0.0663 -0.187 0.073 0.393 
 
 
Table 19. Multivariable logistic regression, in age group 6-23 months (n=180), LBCH EPIC 
population, between January 2010 and June 2012 
 
Variable B Std. Error 95% CI P 
Factor One 0.180 0.0803 0.023 0.338 0.025 
Factor Two -0.004 0.0776 -0.156 0.148 0.955 
Factor Three -0.024 0.0543 -0.130 0.083 0.662 
Factor Four -0.040 0.0752 -0.187 0.108 0.598 
Race (ref is white)      
  Black -0.094 0.1823 -0.451 0.263 0.606 
  Other  -0.198 0.2065 -0.603 0.206 0.337 
Female child 0.043 0.1039 -0.160 0.247 0.676 
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Table 19 (Continued)      
Variable B Std. Error 95% CI P Variable 
Private insurance (ref is 
public) 
0.430 0.1958 0.047 0.814 0.028 
Age of the child -0.047 0.0096 -0.065 -0.028 <0.001 
 
 
Table 20. Multivariable logistic regression, in age group 2-4 years (n=184), LBCH EPIC 
population, between January 2010 and June 2012 
 
Variable B Std. Error 95% CI P 
Domain One 0.336 0.0618 0.215 0.457 <0.001 
Domain Two -0.062 0.0742 -0.207 0.083 0.403 
Domain Three 0.045 0.0730 -0.098 0.188 0.536 
Domain Four -0.250 0.0698 -0.387 -0.113 <0.001 
Race (ref is white)      
  Black 0.020 0.1625 -0.299 0.338 0.903 
  Other  0.016 0.2377 -0.450 0.482 0.946 
Female child 0.146 0.0974 -0.045 0.337 0.133 
Private insurance (ref is 
public) 
0.018 0.1485 -0.273 0.309 0.902 
Age of the child -0.009 0.0048 -0.019 0.000 0.047 
 
 
Table 21. Multivariable logistic regression, in age group 5-9 years (n=156), LBCH EPIC 
population, between January 2010 and June 2012 
 




Domain One 0.237 0.0789 0.082 0.391 8.989 0.003 
Domain Two -0.125 0.0771 -0.276 0.026 2.626 0.105 
Domain Three 0.030 0.0790 -0.125 0.185 0.144 0.704 
Domain Four -0.046 0.0983 -0.239 0.146 0.221 0.638 
Race (ref is white)       
  Black  0.076 0.1521 -0.222 0.374 0.252 0.616 
  Other   -0.107 0.2165 -0.532 0.317 0.246 0.620 
Female child -0.157 0.1125 -0.377 0.064 1.941 0.164 
Private insurance 
(ref is public) 
0.224 0.1249 -0.020 0.469 3.225 0.073 
Age of the child 0.000 0.0033 -0.007 0.006 0.007 0.933 
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Table 22. Multivariable logistic regression, in age group 10-18 years (n=92), LBCH EPIC 
population, between January 2010 and June 2012 
 
Variable 




Domain One 0.366 0.1153 0.140 0.592 10.098 0.001 
Domain Two -0.095 0.1275 -0.345 0.154 0.560 0.454 
Domain Three -0.046 0.1042 -0.246 0.163 0.160 0.689 
Domain Four -0.070 0.1268 -0.338 0.159 0.495 0.482 
Race (ref is white)       
  Black  0.232 0.1665 -0.122 0.530 1.503 0.220 
  Other   0.301 0.2880 -0.258 0.871 1.133 0.287 
Female child 0.093 0.1508 -0.222 0.369 0.236 0.627 
Private insurance (ref is 
public) 
-0.105 0.1570 -0.492 0.123 1.380 0.240 




This study was among the first to evaluate the usefulness of the CARIFS survey in 
assessing disease severity, as defined by LOS, among children with CAP in a hospital setting.  
Questions in the physical function domain represent the symptoms of toxicity which are 
consistent with someone who is really sick and not easily treatable. As a result, our finding that 
these factors, which represent poor appetite and feeling unwell or tired, are most associated with 
a longer LOS is logical. Among those who scored all of these questions with the highest degree 
of severity, the LOS in the hospital was nearly a full day longer compared to those with less 
severity. 
For the most part, this study validated the original domains, from the outpatient setting, 
among this group of hospitalized patients. The original study categorized the CARIFS questions 
into three domains: physical function, parental impact, and clinical symptoms. Our study found 
the first two original domains were similar to the original study and that domain three was split 
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into two separate domains. In our study, domain one represents symptoms of not feeling well 
(constitutional symptoms); domain two represents parental impact factors; domain three 
subjective clinical symptoms of disease; and domain four represents observable or objective 
clinical symptoms of the disease that are objective. With the exception of domain three, 
headache, muscle ache and sore throat, the domains identified in the factor analysis are 
consistent with the original domains. The question related to inability to get out of bed moved 
from the parental impact domain in the original study to the physical function domain in this 
hospitalized population. Additionally, the disrupted sleet and irritability questions moved from 
the physical function domain to the parental impact domain.  
Our study found that the CARIFS scale had high internal consistency, or reliability, in 
this inpatient population among children over the age of six months old. The highest reliability 
was among the oldest age group, 10-18 years old. This finding is consistent with previous 
findings in the outpatient setting.6 Furthermore, consistent with our findings, the authors of the 
CARIFS questionnaire found a high proportion of unanswered questions among respondents 
with children under the age of five for the subjective questions pertaining to headache, sore 
throat, and muscle aches.6 The original study (EPIC) included these questions among the 
younger age groups so we included them in the analysis. Our findings, however, support the need 
to remove these questions when administering the survey to parents evaluating children under 
the age of four years old.  
A limitation of our study is that our data reflect the pediatric experience in one large 
children’s hospital in Memphis, TN. As a result, our findings may not be consistent among other 
patient populations and in other care settings across the U.S. Additional research is needed to 
determine whether or not our findings can be generalized to other demographic populations.  
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While the utility of the CARIFS questionnaire is limited among younger ages, we did 
find the CARIFS questionnaire has good internal reliability among older children. Additionally, 
we found an association between the domain that represents physical function and LOS. Future 
studies should evaluate the individual items in the CARIFS questionnaire.  
Conclusion 
 While the utility of the CARIFS questionnaire is limited among younger ages, we did 
find that it has some promise, based on good internal reliability, among older children. 
Additionally, we found an association with LOS. Because CARIFS consistently predicted LOS, 
this study may provide further information on important factors that may guide the formulation 
of a predictive model. 
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Chapter 4 Identification of Factors that Influence Parental Consent for Participation in 
Hospital-based Pediatric Epidemiologic Research 
Background and significance 
Clinical research is important because it leads to the generation of scientific evidence and 
the adoption of evidence-based practices by healthcare providers, which are more likely to 
improve health outcomes. The best evidence is that which results from well-designed research 
studies that minimize the chances of selection bias. Self-selection bias results when there are 
differences between those who choose to participate in a study and those who do not.19 The 
resulting differences may lead to false conclusions, threatening the validity of a study’s findings. 
Studies with higher participation rates are less vulnerable to this bias than those with lower rates, 
thus minimizing the risk of invalid results.20 As a result, successful recruitment is key; however, 
according to Denhoff21, it is also very challenging. 
“One of the most challenging aspects of conducting clinical research is the ability to 
successfully recruit participants. The inability to recruit the target sample size has been 
estimated to occur in approximately 80% of clinical trials. The impact of low recruitment to a 
study can be serious, leading to early termination with insufficient sample size and 
subsequent losses in statistical power and limited generalizability. In addition, slower than 
anticipated recruitment may increase the duration of the study, delaying the reporting of 
results and causing unanticipated stress on the budget and resources.”19 
To participate in research studies, patients must not only fulfill the inclusion criteria, as 
defined by the study protocol, but also agree to participate in the study after receiving detailed 
information about risks, benefits, and requirements of participation (informed consent). 
Morton, et al. conducted a retrospective review of studies published in the literature from 
January through April 2003.22 “Journals that published peer-reviewed, original research articles 
in English and were listed in the 2003 Science Edition of Journal Citation Reports (The 
Thompson Corporation, Philadelphia, Pennsylvania) were eligible for inclusion.” Their intent 
was to survey the practice of the reporting of participation rates in epidemiologic studies, assess 
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changes in participation over time, and evaluate the impact of increased biologic specimen 
collection on participation. Among the 355 original research studies they identified, a small 
percentage, ranging from 4-32 percent by study type, reported adequate information to evaluate 
the participation rate. Among these, there was a decline in participation over time. Thirty eight 
percent (n=134) of the studies included the collection of biologic specimens to measure exposure 
or disease and the proportion of studies that collected biological specimens increased over time.22 
Twenty seven percent of the studies (n=36) that collected biologic specimens reported a separate 
response rate for the biologic specimen component.22 Among these, there was a high proportion 
of participation among the case-control and cohort studies (86 and 99.5 percent respectively), 
which is likely due, to the participation in the biologic specimen component being mandatory.22  
Parental consent for their child to participate in research is important because it is 
necessary to obtain or maintain funding for clinical studies that ensure research is representative 
of children. Prioritization of the inclusion of children in research is becoming increasingly more 
important to agencies like the National Institutes of Health (NIH). This is evidenced by the need 
to justify the exclusion of children in research protocols.23 Gaining informed consent from the 
parents, who are often the proxy decision-makers for their child's participation in research, has 
unique challenges.  
Despite its importance, there are only a handful of studies in the literature on factors that 
influence parental consent. The current state was summarized by Hoberman24: 
“Research to date of factors influencing a parent’s decision to provide consent for his or her 
child to participate in clinical research has been limited to cancer studies and less-than- 
minimal risk studies. Further, most investigators have collected data only from parents who 
consented to their child’s involvement; very few have examined the motives of parents who 
declined consent. The aggregate of reported findings suggests that the health of the child, 
positive perceptions of the research team and consent process, and altruistic motives play a 
significant role in the decision-making process.” 
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Rothmier25 found that the most important motive for parents when enrolling their child in 
biomedical research is learning more about their child’s illness, followed by the motivation of 
helping medical knowledge. Hoberman24 found that parents who declined participation had more 
anxiety about their decision and found it harder to make a decision, when compared with 
consenting parents, who had higher levels of trust and altruism, stronger expectations for 
enhanced care, and lower levels of decisional uncertainty.24 Parents report that giving consent for 
their child to participate in research is more difficult than giving consent for themselves due to 
the added sense of responsibility, a fear of regretting their decision, and a need to protect their 
child that outweighs their sense of altruism.26 In hospital-based studies, additional motives 
include: not wanting the child to undergo further investigations, research delaying discharge, and 
anxiety regarding written consent and length of information sheets.27 
The role of education status on consent in the literature is mixed. In one study, education-
level of the parent was not shown to influence the consent decision.28 Hoberman,24 however, 
found that parents were more likely to decline consent if they had a college degree, compared to 
less educated parents.  
There are limitations to the studies in the literature. Several of these studies collected data 
only from parents who consented to their child’s involvement25;29; and few have examined the 
motives of parents who declined consent.30-32 Additionally, there is a paucity of information on 
the effect of the inclusion of biological specimens on parental consent.  
The purpose of this study is to examine potential factors associated with parents’ 
decisions to participate in pediatric epidemiologic research. Understanding these factors is 
important to addressing possible barriers for participation 
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Methods 
All English-speaking parents of children who qualified for the EPIC study5 at Le 
Bonheur Children’s Hospital (LBCH) site were approached to participate in this ancillary study 
during the last four months of the study. Participants were asked to complete a 17-item 
questionnaire that included demographic questions and items representing eight potential 
motivating factors. Parents were asked to voluntarily complete the questionnaire after the 
consent discussion and before they signed the study consent.  
The study questionnaire collected information related to: 1) Parent/caregiver 
demographics (e.g., age, race, sex); 2) patient’s health status (e.g., severity of illness; 3) 
parent/caregiver believes and attitude on health research (e.g., altruism, trust in the medical 
system; 4) perceived benefit (e.g., child’s illness and payment); 5) concerns about clinical 
procedures (e.g., blood draws, nose and throat swabs), and 6) study-related communication (e.g., 
clarity of purpose of the study). Figure 1 illustrates the data collection instrument. 
Inclusion and Exclusion criteria 
Inclusion criteria are consistent with the criteria for inclusion in the CDC Etiology of 
Pneumonia in the Community (EPIC) study as follows. Children were  included in the study if 
they were admitted to LBCH; resided in one of the counties in the study catchment areas; had 
evidence of acute infection, defined as reported fever or chills, documented fever or 
hypothermia, leukocytosis or leukopenia; had evidence of an acute respiratory illness, defined as 
new cough or sputum production, chest pain, dyspnea, tachypnea, abnormal lung examination, or 
respiratory failure, and had evidence consistent with pneumonia as assessed by means of chest 
radiography within 72 hours before or after admission.5 
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Children were excluded if they were not enrolled into the study within 72 hours of 
admission or declined participation, had been hospitalized recently (<7 days for 
immunocompetent children and <90 days for immunosuppressed children), had been enrolled in 
the EPIC study within the previous 28 days, resided in an extended-care facility, had an 
alternative diagnosis of a respiratory disorder or were newborns who never left the hospital. 
Children were also excluded if they had a tracheostomy tube, if they had cystic fibrosis or cancer 
with neutropenia, if they had received a solid-organ or hematopoietic stem-cell transplant within 
the previous 90 days, if they had active graft-versus-host disease or bronchiolitis obliterans or if 
they had human immunodeficiency virus infection with a CD4 cell count of less than 200 per 
cubic millimeter (or a percentage of CD4 cells <14%). Children with a clear alternative non-
pneumonia diagnosis were also excluded.5 
Study sample  
English-speaking parents of children with respiratory illness who were admitted to LBCH 
between January and June 2012, and found eligible to participate in EPIC study, were 
approached to complete the survey. Survey completion took place after the consenting discussion 
but before the parent consented to the study. 
Study variables 
Outcome. Parental consent for child to participate in the EPIC study, as a binomial 
response (yes/no).  
Main independent variables. Survey responses to the following questionnaire items: 1) 
my child’s illness is an important factor; 2) this study is an important part of improving medical 
care; 3) purpose of the study was clearly explained; 4) my information will be kept private; 5) 
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concern about blood collection; 6) concern about nose/throat swab; 7) concern over the follow-
up visit, and 8) payment is an important factor.  
Covariates. Demographic variables including: age, race, employment status and sex of 
the parent; household education; insurance status; frequency of hospitalization and severity of 
the child’s illness. Table 23 provides a description of the independent variables. 
 




Age of the parent/caregiver Years  
Gender of the parent/caregiver Male/Female 
Race of the parent 
Non-Hispanic black, non-Hispanic white,  
Hispanic, other 
Highest household educational status 
<high school, high school graduate, some 
college, college graduate/advanced degree 
Employment status 
Employed, not employed, student, 
homemaker, disabled 
Marital status 
Married/non-married couple, never 
married, divorced, separated, widowed 
Frequency of child’s hospitalization Number of time, past 5 years 
Insurance type Public, private, both or self-pay 
Number of children Living in the household (continuous) 
Motivational Factors 
My child’s illness in an important factor  
5-point Likert scale; strongly disagree, 
disagree, neutral, agree and strongly agree 
I feel that this study is an important part of 
improving medical care 
5-point Likert scale 
The purpose of the study was clearly explained to 
me 
5-point Likert scale 
I feel my information will be kept private 5-point Likert scale 
I am concerned about the blood collection 5-point Likert scale 
I am concerned about the nose and throat swab 5-point Likert scale 
I am concerned about the follow-up visit 5-point Likert scale 




Summary descriptive statistics were calculated using frequency distributions and means 
as appropriate (Table 24 and Table 25). Logistic regression was used to estimate the crude 
association of each demographic and motivational variable with consenting to participate. Odds 
rations and p values were generated. Adjusted odds rations and their 95% confidence intervals 
were calculated using a fixed-effects logistic regression model. Variables associated with 
outcomes on bi-variable analyses as defined by a significance of 0.3 or less were included in the 
multivariable model. Stepwise backward elimination method with an elimination cut off 
threshold of p<0.05 was used to arrive at the final model. Because of the exploratory nature of 
the study, a less stringent level of 0.3 was used to ensure all potentially important variables were 
included in the multivariable model. 
Marital status was categorized into married and not married. The non-married category 
combined divorced, separated, and single. Employment status was categorized into employed 
(self-employed and employed by others), not employed, and other (student/retired/disabled). The 
responses for the motivational factors were included as a continuous variable with a scale coded 
from one to five strongly disagree to strongly agree. 
Collinearity between variables was assessed using Variation Inflation Factors (VIF) 
values. A VIF value over three for any variable was considered indicative of multicollinearity. 
Tests of statistical significance were two sided, with an alpha level of 0.05, and are reported with 
three significant digits. All analyses were conducted with SPSS version 24 (IBM).16 
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Results 
Two hundred sixty two out of the 388 eligible parents (67.5%) completed the survey. 
Among those who completed a survey, 181(69%) consented to participate in the EPIC study. 
Figure 4 displays a flowchart of the study.  
 
Figure 4. Consort diagram of respondents who completed a survey of motivating factors for 
research as part of the EPIC study at LBCH 
 
Mean age (SD) of the respondents was 30 years (7.97). Two hundred and sixteen (82.4%) 
of the participants were female, 167 (63.7%) were African American, and 70 (26.7%) had at 
least a college degree. One hundred fifty (56%) had public health insurance. Among those who 
completed the survey, 181(69.1%) consented to participate in the EPIC study. 
 
  
Eligible to participate in EPIC (n = 388) 
Did not complete the 
survey (n = 126) 
Completed the survey 
(n = 262) 
Consented to participate 
No (n = 81) Yes (n = 181) 
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Table 24. Demographic characteristics of LBCH EPIC study participants, between January and 
June 2012  
 
Characteristic N (n=262) % 
Gender   
  Male 39 14.9 
  Female 216 82.4 
  Missing 7 2.7 
Age   
  15–24 79 30.0 
  25–34 109 42.0 
  35+ 61 23.0 
  Missing 13 5.0 
Race   
  Caucasian 77 29.4 
  African American 167 63.7 
  Hispanic 10 3.8 
  Other  8 3.1 
Education   
  < High School Grad 57 21.8 
  High School Grad 58 22.1 
  Some College 76 29.0 
  College Graduate 53 20.2 
  Advanced Degree 17 6.5 
  Missing 1 0.4 
Employment   
  Employed 156 59.5 
  Not Employed 64 24.4 
  Other (ret/stud/DA) 39 14.9 
  Missing 3 1.1 
Insurance     
  Public 150 57.3 
  Private 82 31.3 
  None 24 9.2 
  Missing 6 2.3 
Marital status     
  Married/Couple 120 45.8 
  Never married 112 42.7 
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Table 24 (Continued) 
Characteristic N (n=262) % 
  Divorced 10 3.8 
  Separated 9 3.4 
  Widowed 4 1.5 
  Missing 7 2.7 
Children in household   
  None 2 0.8 
  One 68 26.0 
  Two 80 30.5 
  Three 62 23.7 
  ≥Four 49 18.7 
  Missing 1 0.4 
Severity of child’s illness     
  Not sick 15 5.7 
  Somewhat sick 29 11.1 
  Moderately sick 103 39.3 
  Very sick 113 43.1 
  Missing 2 0.8 
Hospitalizations of child during past 5 years     
  0 93 35.5 
  1 53 20.2 
  2 55 21.0 
  3+ 60 22.9 
  Total 262 100.0 
 
 
Table 25. Positive and negative responses for each motivational factor, LBCH EPIC study 
participants, between January and June 2012  
 
Motivational Factor 
Total Agree* Disagree* 
N N % N % 
The purpose of the study was clearly explained to 
me 
260 256 97.7 2 0.8 
I feel my information will be kept private 261 243 92.7 3 1.1 
I feel that this study is an important part of 
improving medical care 
259 226 86.3 7 2.7 
My child’s illness in an important factor  253 217 82.8 11 4.2 
I am concerned about the blood collection 259 109 41.6 90 34.4 
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Table 25 (Continued) 
Motivational Factor 
Total Agree* Disagree* 
N N % N % 
I am concerned about the nose/throat swab 258 102 38.9 101 38.5 
I am concerned about the follow-up visit 258 97 37.0 110 42.0 
Payment is an important factor  250 39 14.9 161 61.5 




Mothers were more likely to consent (OR = 1.88, 95% CI = 0.93, 3.77). Greater severity 
of illness was also associated with increased parental consent (OR = 1.29, 95% CI = 0.96, 1.75). 
Parents with a college degree were two times less likely to give consent compared to no college 
degree. Single parents were more likely to give consent than those who were married (OR = 
1.59, 95% CI = 0.94, 2.71). As severity of illness and the number of children in the household 
increased, parental participation increased. Parental consent did not differ by race, employment 
status, or number of prior hospitalizations (Table 26). Younger parents, those who were single, 
and those with lower household education levels were more likely to participate. 
Parents who agreed that the study is an important part of improving medical care were 
approximately three times more likely to participate than those who did not agree or were 
neutral; those who agree that their child’s illness will be improved through the research were two 
times more likely to participate; those who believe the information will be kept private were 
nearly three times more likely to participate. Parents who had concerns about blood collection 
and nose and throat swabs were approximately 40% less likely to participate than those parents 




Table 26. Unadjusted odds ratios of study variables with study participation, LBCH EPIC study 
participants, between January and June 2012  
  
Demographic Variables OR 95% CI P 
Age (ref is 15-24)     
  25-34 0.55 0.29 1.06 0.076 
  35+ 0.65 0.31 1.39 0.267 
Gender (ref is male) 1.88 0.93 3.77 0.077 
Education (ref is ≥ college graduate)     
  Some high school 2.04 0.97 4.29 0.062 
  High school graduate 2.75 1.27 5.98 0.011 
  Some college 2.08 1.05 4.15 0.037 
Employment (ref is employed)     
  Unemployed 0.91 0.49 1.70 0.767 
  Other 0.84 0.37 1.95 0.692 
Insurance (ref is public)     
  Private 0.54 0.31 0.96 0.034 
  Self-pay 0.88 0.34 2.29 0.798 
Marital Status (ref is married/couple) 1.59 0.94 2.71 0.087 
Race (ref is Caucasian)     
  African American 1.03 0.57 1.85 0.921 
  Hispanic/Other 0.91 0.30 2.70 0.859 
Number of Children 1.23 0.96 1.57 0.108 
Hospitalizations of child during past 5 years 0.93 0.76 1.15 0.511 
Severity of Child’s Illness 1.29 0.96 1.75 0.093 
Motivating Factors     
My child's illness is an important factor in my 
decision to participate 
2.01 1.47 2.75 <0.001 
I feel that this study is an important part of 
improving medical care 
3.30 2.24 4.88 <0.001 
I feel my information will be kept private 2.85 1.86 4.38 <0.001 
The purpose of this study was clearly explained to 
me 
1.78 1.11 2.87 0.018 
I am concerned about the blood collection  0.62 0.50 0.78 <0.001 
I am concerned about the nose and throat swab  0.60 0.48 0.75 <0.001 
I am concerned about the follow-up visit  0.83 0.68 1.01 0.063 
Payment is an important factor in my decision to 
participate  





Table 27 shows the adjusted associations with parental study participation. Household 
education level and several motivational factors including: the ability to learn more about their 
child’s illness, altruism, clear understanding of the study purpose and concerns about the 
collection of biological specimens are all important factors for parental consent or participation. 
There was an inverse association between participation and education. Parents with the lowest 
levels of education were the most likely to give consent for their child to participate; 
furthermore, as education level increased, the likelihood of consent declined. Those who agreed 
with the statement that represented altruism, “I feel that this study is an important part of 
improving medical care” were three and a half times more likely to participate than those who 
did not (OR = 3.64, 95% CI = 2.20, 6.02).  
Parents who agreed that their child’s illness is an important factor in their decision to 
participate were one and a half times more likely to participate (OR = 1.59, 95% CI = 1.06, 2.39) 
than those who disagreed. Parents with concerns about the nose and throat swab were half as 
likely to give consent for their child to participate in the study compared to those who did not 
have concerns (OR = 0.48, 95% CI = 0.36, 0.65). Counter to the unadjusted finding, in the 
adjusted model, those who agreed that the study was clearly explained to them were less likely to 
participate. 
 
Table 27. Adjusted odds ratios of factors associated with study participation, LBCH EPIC study 
participants, between January and June 2012  
 
 
Variable OR 95% CI P 
Education – reference is ≥ college graduate     
  Some high school 4.78 1.75 13.05 0.002 
  High school degree 3.51 1.34 9.18 0.011 
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Table 27 (Continued)     
Variable OR 95% CI P 
  Some college 2.91 1.21 6.98 0.017 
My child's illness is an important factor in my decision 
to participate 
1.59 1.06 2.39 0.025 
I feel that this study is an important part of improving 
medical care 
3.64 2.20 6.02 <0.001 
The purpose of this study was clearly explained to me 0.45 0.22 0.93 0.032 
I am concerned about the nose and throat swab 0.48 0.36 0.65 <0.001 
 
 
The VIF did not exceed three for any of the variables in the multi-variable model 
indicating that there was no multicollinearity between the variables in the model.  
Discussion 
As study participation rates decline over time, it is important to understand the factors 
that are associated with parental consent to increase participation rates and decrease the chance 
of bias. Furthermore, as the collection of biologic specimens increases, it is important to 
understand the effect that this has on parental consent for participation, yet there are few if any 
published studies on this topic. As a result, this study evaluated attitudes toward predefined 
motivational factors that may be associated with parental consent to participate in pediatric 
research.  
In our study, we found that parents who consented to research had lower levels of 
household education, were interested in learning more about their child’s illness and were 
interested in improving medical care. They were less likely to consent if they had concerns about 
the nose and throat swab. More research is necessary to understand the nuances of clear 
explanation of the purpose of the study. 
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Our findings are consistent with the literature regarding the positive association of 
altruism and improving care for others to parents’ decision to allow their child to participate in 
research. Additionally, we found that parents were more likely to consent if they believed that 
the study would allow them to learn more about their child’s illness. While findings in the 
literature are mixed, our findings were consistent with Hoberman, et al.22, regarding the 
increased likelihood of parents to consent to participation if their household education level was 
below a college degree. Parental consent did not differ by age, race, employment status, or 
number of prior hospitalizations.  
A limitation of our study is that there may be other factors that are associated with 
parental consent but were not included in this study. Examples from the literature include 
respondents’ perception of the research team, anxiety level and decisional uncertainty.  
A second limitation is the small sample size which prevented us from evaluating the 
interaction between education level and each of the motivational factors. Additionally, 
generalizability is a limitation. Because our data reflect the parental attitudes from one large 
children’s hospitals in Memphis, TN, our findings may not be consistent among other patient 
populations across the U.S. Additional research is needed to determine whether or not our 
findings can be generalized to other demographic populations.  
Conclusion 
Overcoming barriers to parental consent in pediatric research is important because it may 
reduce selection bias resulting from low participation rates which can affect study findings. To 
our knowledge, this is one of the first to assess important associations like the effect of the 
collection of biological specimens on parental consent. 
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We found parents who cared about improving medical care and who had a desire to learn 
more about their child’s condition gave consent more frequently than those who did not; while 
concerns over the collection of biological specimens, like a nose and throat swab, may result in 
lower participation. Finding ways to mitigate concerns of parents about the biological specimen 
collection, for example, less invasive means for collecting specimens, may increase participation 
by as much as 60 percent.  
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Chapter 5 Summary 
The EPIC study provided robust and unique datasets that were used to investigate the 
aims of these three studies and to begin to address important questions in the literature.  
With these data, we assessed predictive factors associated with potentially unnecessary 
hospitalizations among different age groups of children with pneumonia. The ultimate goal was 
to provide evidence for developing a decision support rule that could be used to better manage 
pediatric pneumonia and reduce the number of unnecessary hospitalizations. Our findings, 
however, were not enough to achieve this goal.  
While the utility of the CARIFS questionnaire is limited among younger ages, our study 
was the first to find that it had high internal consistency among an inpatient population of 
children with pneumonia. Furthermore, our findings suggest that the CARIFS survey may 
provide a means for predicting LOS in the hospital upon admission among older children.  
Our findings suggest that motivational factors play an important role in the decision of 
parents to give consent for their children to participate in research. We found that parents who 
believe their child’s participation in research will lead to an increase in their knowledge about 
their child’s illness or contribute to the wellbeing of other children (altruism) are more motivated 
to participate in research. Furthermore, finding ways to mitigate the concerns parents have about 
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